Phase I trial of intratumoral EGFR antisense DNA and DC-Chol liposomes in advanced oral squamous cell carcinoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antisense EGFR gene therapy (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions; Therapeutic Use
- 12 Feb 2016 Biomarkers information updated
- 09 Sep 2005 New trial record.